UB Paderborn / Katalog / Suche / in CDI

Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S75-S75

2016

Volltextzugriff (PDF)

Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S383-S383

2016

Volltextzugriff (PDF)

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

Psychopharmacology, 2021-07, Vol.238 (7), p.1899-1910

2021

Volltextzugriff (PDF)

Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure

Psychopharmacology, 2016-09, Vol.233 (18), p.3331-3340

2016

Volltextzugriff (PDF)

Spontaneous and deliberate creative cognition during and after psilocybin exposure

Translational psychiatry, 2021-04, Vol.11 (1), p.209-209, Article 209

2021

Volltextzugriff (PDF)

Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

British journal of pharmacology, 2018-01, Vol.175 (1), p.18-28

2018

Volltextzugriff (PDF)

Excretion of 4-fluoroamphetamine and three metabolites in urine after controlled oral ingestion

Journal of pharmaceutical and biomedical analysis, 2020-02, Vol.179, p.113008, Article 113008

2020

Volltextzugriff (PDF)

Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Scientific reports, 2016-05, Vol.6 (1), p.26843, Article 26843

2016

Volltextzugriff (PDF)

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine

Psychopharmacology, 2018-08, Vol.235 (8), p.2349-2356

2018

Volltextzugriff (PDF)

Chiral Serum Pharmacokinetics of 4-Fluoroamphetamine after Controlled Oral Administration: Can (R)/(S)-Concentration Ratios Help in Interpreting Forensic Cases?

Journal of analytical toxicology, 2021-11, Vol.45 (9), p.985-992

2021

Volltextzugriff (PDF)

Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans

Psychopharmacology, 2015-01, Vol.232 (2), p.343-353

2015

Volltextzugriff (PDF)

Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy

Thrombosis and haemostasis, 2011-01, Vol.105 (1), p.169

2011

Volltextzugriff (PDF)

Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity

Journal of psychopharmacology (Oxford), 2015-03, Vol.29 (3), p.324-334

2015

Volltextzugriff (PDF)

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

Frontiers in pharmacology, 2018-07, Vol.9, p.713-713

2018

Volltextzugriff (PDF)

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

Brain imaging and behavior, 2016-12, Vol.10 (4), p.1254-1263

2016

Volltextzugriff (PDF)

[LB.01.02] PHASE II RANDOMIZED SHAM-CONTROLLED STUDY OF RENAL DENERVATION FOR SUBJECTS WITH UNCONTROLLED HYPERTENSION – WAVE IV

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e21-e21

2017

Volltextzugriff (PDF)

Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

British journal of pharmacology, 2013-12, Vol.170 (7), p.1410-1420

2013

Volltextzugriff (PDF)

Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication

Addiction biology, 2017-05, Vol.22 (3), p.823-832

2017

Volltextzugriff (PDF)

Analysis of 4‐fluoroamphetamine in cerumen after controlled oral application

Drug testing and analysis, 2020-07, Vol.12 (7), p.968-974

2020

Volltextzugriff (PDF)

Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication

Human psychopharmacology, 2018-11, Vol.33 (6), p.e2680-n/a

2018

Volltextzugriff (PDF)

A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State

Journal of psychoactive drugs, 2019-05, Vol.51 (3), p.225-235

2019

Volltextzugriff (PDF)

Erratum: Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Scientific reports, 2016-09, Vol.6 (1), p.31939-31939, Article 31939

2016

Volltextzugriff (PDF)

Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy

Multiple sclerosis, 2013-02, Vol.19 (2), p.249-251

2013

Volltextzugriff (PDF)

Regional Distribution and Developmental Changes of GluR1‐Flop Protein Revealed by Monoclonal Antibody in Rat Brain

Journal of neurochemistry, 1999-11, Vol.73 (5), p.2195-2205

1999

Volltextzugriff (PDF)

1H-MR-Spektroskopie des zervikalen Myelons bei Patienten mit MS

Nervenarzt, 2010-10, Vol.81 (Suppl 1), p.14-15

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients

Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure

Spontaneous and deliberate creative cognition during and after psilocybin exposure

Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

Excretion of 4-fluoroamphetamine and three metabolites in urine after controlled oral ingestion

Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine

Chiral Serum Pharmacokinetics of 4-Fluoroamphetamine after Controlled Oral Administration: Can (R)/(S)-Concentration Ratios Help in Interpreting Forensic Cases?

Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans

Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy

Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

[LB.01.02] PHASE II RANDOMIZED SHAM-CONTROLLED STUDY OF RENAL DENERVATION FOR SUBJECTS WITH UNCONTROLLED HYPERTENSION – WAVE IV

Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication

Analysis of 4‐fluoroamphetamine in cerumen after controlled oral application

Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication

A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State

Erratum: Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy

Regional Distribution and Developmental Changes of GluR1‐Flop Protein Revealed by Monoclonal Antibody in Rat Brain

1H-MR-Spektroskopie des zervikalen Myelons bei Patienten mit MS

Suchergebnisse filtern